a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.[1] The company does not have any other product but the Pfizer–BioNTech COVID-19 vaccine (BNT162b2). The company received 55 million USD in September 2019 from the Bill & Melinda Gates-Foundation.[2][3] Founded in 2008 by Turkish married scientists Özlem Türeci and Ugur Sahin and the Austrian oncologist Christoph Huber, the company originally set out to develop new types of immunotherapy against cancer, modifying patients’ T cells to target cancer-specific antigens. It researches drugs based on messenger RNA (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer.
BioNTech developed an mRNA-based human therapeutic for intravenous administration, to bring individualized mRNA-based cancer immunotherapy to clinical trials and to establish its own manufacturing process.[4]
COVID-19 vaccine
“A year ago today, not everyone was aware that we were going to live in a pandemic. But some already knew or suspected it; and that included Mr. Şahin, the head of BioNTech, who told me that on January 24 he made the decision to overturn the entire BioNTech research program and develop an mRNA vaccine for this virus.”
Angela Merkel (26 Januar 2021) [5]
The company’s shares shot up 23.4% on Monday morning after the Covid-19 vaccine it is developing with the US pharma giant Pfizer became the first candidate worldwide to show positive results in phase 3 trials, the crucial final stage of testing.
In November 2020, The Guardian reported that “the total value of BioNTech’s stock is currently $21.9bn (£16.6bn), more than four times that of German national carrier Lufthansa and a triumph for a company that only made its debut on the US stock market a year ago.”[6]
Approved for use
On 21 December 2020, following approval by the UK’s MHRA and the US FDA, the European Medicines Agency (EMA) authorized the Pfizer BioNTech Covid-19 vaccine for the EU’s nearly 448 million inhabitants. The EMA said the drug had demonstrated an efficacy of 95% and could be used in people aged 16 and over: :”Today’s positive news is an important step forward in our fight against this pandemic, which has caused suffering and hardship for so many,” said the EMA’s executive director, Emer Cooke. “Our thorough evaluation means that we can confidently assure EU citizens of the safety and efficacy of this vaccine and that it meets necessary quality standards. However, our work does not stop here. We will continue to collect and analyze data on the safety and effectiveness of this vaccine to protect people taking the vaccine in the EU.”[7]
Source: Wikispooks
Chronological History of Events Related to BioNTech
Whistleblower: The Pentagon Mandated COVID Vaccines, But Then Ignored Concerns About Adverse
Pfizer and BioNTech Team with Marvel Comics for Children’s Propaganda Comic Book for Covid Vaccine
Pfizer Document Dump Shows Doctor With Ties to Gates Foundation Deleted Trial Participant’s Vaccine Injury
AFFIDAVIT OF LTC. THERESA LONG M.D. IN SUPPORT OF A MOTION FOR A PRELIMINARY INJUNCTION ORDER
The German Club of Clear Words Report: Exposes the network of individuals and organizations responsible for the COVID scam
Moderna Trial Documents: Lab Rat Offspring Got Rib Malformations After COVID Vaccination
Pfizer lied about death count in key covid “vaccine” clinical trial – fatalities were MUCH higher
Qatar Signs Deal To Buy Moderna COVID-19 Vaccine
